Diagnosis

Portal hypertension

Portal pressure >10 mm Hg measured indirectly with the hepatic venous pressure gradient of ≥6 mm Hg.

Etiology

Cause [y0v][5kp]

  1. Prehepatic:

    Portal atresia, portal vein thrombosis, tumor compression, AV-fistula (increased flow)

  2. Intrahepatic: Changes in hepatic microcirculation --> structural changes --> fibrosis, regenerative nodules, vascular occlusion, angiogenesis, vasoconstriction

    • Presinusoidal: Schistosomiasis, fibrosis (hemochromatosis, Wilson, congenital), early primary biliary cholangitis, sarcoidosis, chronic active hepatitis, and toxins (vinyl chloride, arsenic, and copper)

    • Sinusoidal: Cirrhosis, alcohol-related hepatitis, vitamin A intoxication, cytotoxic drugs, and advanced primary biliary cholangitis

    • Postsinusoidal: sinusoidal obstruction syndrome due to veno-occlusive disease

  3. Posthepatic: Budd-Chiari syndrome, tumor compression of IVC, heart failure (constrictive pericarditis, tricuspid insufficiency, restrictive cardiomyopathy)

  4. Idiopathic portal hypertension

Pathophysiology [5kp][y0v]

  1. The portal vein pressure is normally between 1 and 4 mm Hg (higher than the hepatic vein pressure)

  2. Increased resistance to portal blood flow --> portal hypertension

  3. Portosystemic collaterals: caput medusa, hemorrhoids, esophageal varices

  4. Sustained portal hypertension result in

    • Decreased systemic blood pressure

    • Reduced effective arterial blood volume.

    • Activation of the renin-angiotensin-aldosterone system --> Na and H2O retention

    • Bacterial translocation from the gut lumen to the systemic circulation

  5. Hepatic venous pressure gradient ≥12 mm Hg --> decompensation:

    • Ascites

    • Variceal bleeding

    • Hepatic encephalopathy

Complications [5kp]

Epidemiology

Incidence per 100.000 [vcd][sgc][ids][f5r]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Caput medusa, Coma, Decreased consciousness, Edema, Hematemesis, Hematochezia, Hemorrhoids, Icterus, Lethargy, Obesity, Spider nevus, Splenomegaly

Clinical findings

Ascites, Gynecomastia, Jaundice, Palmar erythema

Anamneses

None listed.

Localized findings

Rash
Radiates
Hand
Distribution
Symmetric
Lesion type
Erythema
Color
Red
Palpation
Blanching
Swelling
Radiates
Abdomen
Onset
Gradual (days)
Pattern
ConstantIncreasing

Approach

Treatment

  1. Identify and address the underlying etiology [5kp]

    • Thrombosis --> anticoagulation

    • Hepatitis C infection --> antiviral therapy

  2. Medical treatment: [ccf][y0v]

    • Splanchnic vasoconstrictors:

      • Vasopressin (IV)

      • Somatostatin (IV): Octreotide, Vasopressin, Terlipressin

      • Nonselective beta-adrenergic blockers: propranolol or nadolol (oral)

        β1-blockade (reduction of cardiac output)

        β2-blockade (splanchnic vasoconstriction)

    • Analogues of nitric oxide (NO): nitrates and simvastatin

    • Block adrenergic activity: prazosin and clonidine

    • Block angiotensin: captopril, losartan, and irbesartan (induce intrahepatic vasodilatation)

  3. Local therapy: risk of recurrence --> endoscopic surveillance

    • Esophageal variceal ligation (endoscopic elastic bands)

    • Variceal sclerotherapy (endoscopic)

    • Balloon tamponade

    • Expandable esophageal stents

    • Percutaneous transhepatic embolization

  4. Transjugular Intrahepatic Portosystemic Shunt (TIPS)

  5. Surgery: severe cirrhosis/esophageal varices and/or liver failure

    • Portosystemic shunts

    • Liver transplantation

Differential diagnoses

Acute liver failure, Ascites, Budd-Chiari syndrome, Cirrhosis, Congenital atresia, Congenital fibrosis, Hemochromatosis, Leukemia, Lymphoreticular cancer, Pericarditis, Polycystic kidney disease, Portal vein thrombosis, Sarcoidosis, Schistosomiasis, Splenomegaly, Tricuspid regurgitation, Tuberculosis, Vitamin deficiency, Wilson's disease


References

[1] http://emedicine.medscape.com/article/182098 (2014-01-02); [Medscape]

[2] Oliver TI, Sharma B, John S. Portal Hypertension. [Updated 2025 Jul 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507718/

[3] Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. J Hepatol. 2008 Nov;49(5):732-8.

[4] Devarbhavi, Harshad et al. Global burden of liver disease: 2023 update. Journal of Hepatology, Volume 79, Issue 2, 516 - 537.

[5] Mendes FD, Suzuki A, Sanderson SO, Lindor KD, Angulo P. Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2012 Sep;10(9):1028-33.e2.

[6] Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, Volk ML. The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol. 2015 Sep;49(8):690-6.

[7] Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010 Mar 4;362(9):823-32.

Scroll to top